Part 1: Advances in our Understanding of Resistance to Trastuzumab

Part 2: An Update on Adjuvant Therapy with Trastuzumab

Part 3: An Update on the Use of Lapatinib

Part 4: New Drugs for HER2-Positive Metastatic Breast Cancer: Trastuzumab-DM1, Neratinib, and Tanespimycin

Authors
Part 1 and Part 4
Ron Bose, MD, PhD
Assistant Professor
Division of Oncology
Department of Internal Medicine
Washington University School of
Medicine
St. Louis, Missouri

Part 2 and Part 3
Cynthia X. Ma, MD, PhD
Assistant Professor
Division of Oncology
Department of Internal Medicine
Washington University School of
Medicine
St. Louis, Missouri

Brian Andrew Van Tine, MD, PhD
Clinical Fellow
Division of Medical Oncology
Physician Scientist Training Program
Department of Internal Medicine
Washington University School of Medicine
St. Louis, Missouri

Yee H. Chia, MD
Clinical Fellow
Division of Medical Oncology and Hematology
Department of Internal Medicine
Washington University School of Medicine
St. Louis, Missouri